This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Scandinavian ChemoTech Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Scandinavian ChemoTech has a total shareholder equity of SEK7.9M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK16.2M and SEK8.3M respectively.
Belangrijke informatie
0%
Verhouding schuld/eigen vermogen
SEK 0
Schuld
| Rente dekkingsratio | n/a |
| Contant | SEK 1.66m |
| Aandelen | SEK 7.89m |
| Totaal verplichtingen | SEK 8.32m |
| Totaal activa | SEK 16.21m |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: CMOTEC BTA B's short term assets (SEK9.0M) exceed its short term liabilities (SEK8.3M).
Langlopende schulden: CMOTEC BTA B has no long term liabilities.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: CMOTEC BTA B is debt free.
Schuld verminderen: CMOTEC BTA B has no debt compared to 5 years ago when its debt to equity ratio was 2.2%.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: CMOTEC BTA B has sufficient cash runway for 1 months based on last reported free cash flow, but has since raised additional capital.
Voorspelling contante baan: CMOTEC BTA B is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.